Tandem Diabetes Care Aktie
15,40
EUR
-0,80
EUR
-4,94
%
21,78
USD
+2,96
USD
+15,73
%
Tandem Diabetes Care jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Tandem Diabetes Care Aktie Analyse
| 08.03.19 | Tandem Diabetes Care Outperform | BMO Capital Markets | |
| 27.02.19 | Tandem Diabetes Care Buy | Lake Street | |
| 26.09.18 | Tandem Diabetes Care Buy | Dougherty & Company LLC | |
| 14.09.18 | Tandem Diabetes Care Neutral | Robert W. Baird & Co. Incorporated | |
| 24.08.18 | Tandem Diabetes Care Buy | Dougherty & Company LLC | |
| 22.08.18 | Tandem Diabetes Care Hold | Stifel, Nicolaus & Co., Inc. | |
| 31.07.18 | Tandem Diabetes Care Hold | Stifel, Nicolaus & Co., Inc. |
Werbung
Werbung